Clinical trial
Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral…
NCT00102908 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Unknown status
Key facts
| NCT number | NCT00102908 |
|---|---|
| Title | Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density |
| Official title | Bisphosphonate Therapy for HIV-Associated Osteopenia |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Osteopenia, Osteoporosis |
| Intervention type | Drug |
| Interventions | Zoledronate, Zoledronate placebo |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2009 |
| First posted | Feb 7, 2005 |
| Last update posted | Sep 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: